NCI (01336) surged over 3%, trading at HK$49.8 by press time with a turnover of HK$225 million. The company reported robust Q1-Q3 2025 results: revenue reached RMB137.25 billion (+28.3% YoY), while net profit attributable to shareholders climbed 58.9% to RMB32.86 billion. Basic EPS stood at RMB10.53.
Key operational highlights include: - Gross written premiums: RMB172.71 billion (+18.6% YoY) - First-year long-term premiums: RMB54.57 billion (+59.8%) - First-year regular-premium long-term policies: RMB34.9 billion (+41%) - Single-premium long-term policies: RMB19.67 billion (+109.2%) - Renewal premiums: RMB114.62 billion (+5.9%), maintaining stable contribution.
Guosen Securities noted NCI's stellar performance was primarily driven by exceptional investment returns amid Q1-Q3 capital market recovery, building on last year's high base. On the liability side, New Business Value (NBV) soared 50.8%, laying solid groundwork for future profit growth.
Notably, to address challenges from regulatory rate cuts, NCI has actively pivoted to dividend insurance products since Q2, making them a strategic focus across all distribution channels.
Comments